Digital pathology is a boon for pathologists and patients as it enables rapid diagnosis. Advanced technologies such as artificial intelligence (AI) and others will be utilized for offering better services than before.
Digital pathology is a boon for pathologists and patients as it enables rapid diagnosis. Advanced technologies such as artificial intelligence (AI) and others will be utilized for offering better services than before. Market players have realized the potential of digitization of pathology laboratories and adopted the strategy of partnership. This strategy is aimed at utilizing the expertise and resources to create advanced digital pathology solutions and provide rapid diagnosis. A unified platform will be created through integration of different technologies and tools to offer advanced solutions for laboratories. Moreover, services will be expanded to new regions as digitization becomes a priority. The demand for innovative and rapid digital pathology solutions will increase in the next few years. According to the report published by Allied Market Research, the global digital pathology market is expected to reach $1.79 billion by 2030. Following are some of the activities taking place across the world.
Partnership has become a major strategy to develop solutions for clinical diagnosis with the help of digital pathology. An AI-based digital pathology software provider Crosscope partnered with AI tools developer Mindpeak. This partnership is aimed at expanding the portfolio of AI applications and offering end-to-end digital pathology solutions. Dr. Jayendra Shinde, the CEO at Crosscope, highlighted that this strategic partnership will leverage the strengths of both companies for development of solutions for Histopathology workflows and integrate all the AI tools in a single platform.
The integration of various image analysis solutions for PR, ER, and Ki-67 IHC staining will be carried out in the platform. It will help pathologies in enhancing efficiency and providing rapid diagnosis. The AI software BreastIHC by Mindpeak will be integrated into the Crosscope’s platform across different countries such as the U.S., India, and others. This partnership will also lead to adoption of AI in pathology solutions.
Download Sample Report- https://www.alliedmarketresearch.com/request-sample/74
The trend of partnership continues with market players aiming to expand into new regions. The National Pathology Imaging Co-operative (NPIC) partnered with medical imaging and cyber-security firm Sectra. This strategic partnership aims to utilize digital pathology solutions and enhance diagnosis of patients throughout the U.K. Laboratories in different parts of the U.K. will be able to digitize their pathology services. Many laboratories will be benefited as there is a lack of expertise on how to digitize the pathology services and necessary funding to carry out the digitalization. The partnership also enables NPIC to develop two new specialist networks of digital pathology in sarcoma tissue cancers and pediatrics.
Key Findings of the Study
- On the basis of type, the scanners segment was the highest contributor to the market in 2020.
- On the basis of application type, the disease diagnosis segment dominated the market in 2020, and is expected to continue this trend during the forecast period.
- On the basis of end user, the pharma & biotech companies segment was the highest contributor to the market in 2020.
- On the basis of region, North America garnered the largest revenue share in 2020, whereas Asia-Pacific is anticipated to grow at the highest 10.6% CAGR during the forecast period.